Key result
FGM detects ~3x more hypoglycemia than standard monitoring, identifying an independent predictor of cardiogenic shock.
Why the study?
Altered blood glucose is linked to worse outcomes in critical illness, particularly hypoglycemia. This study investigated the link between flash glucose monitoring variables and cardiogenic shock in critically ill CCU patients.
Does flash glucose monitoring predict cardiogenic shock occurrence in critically ill CCU patients?
Observational (n=28)
Does flash glucose monitoring predict cardiogenic shock occurrence in critically ill CCU patients?
Flash glucose monitoring identifies more hypoglycemic events than standard monitoring in the CCU, and these events are independent predictors of cardiogenic shock.
Answers are grounded in this paper and cite their sources.
Flash-detected hypoglycemia may signal cardiogenic shock risk in CCU patients; hypothesis-generating and requires prospective validation.
Background/Objectives: Continuous and flash glucose monitoring (CGM and FGM) may enhance glucose management by providing real-time glucose data. Furthermore, growing evidence is linking altered blood glucose concentrations and worse short-term outcomes in critically ill patients. While hyperglycemia is more common in these patients and is associated with an increased risk of adverse events, hypoglycemia is particularly concerning and significantly raises the risk of fatal outcomes. This exploratory study investigated the link between FGM variables and cardiogenic shock in critically ill Coronary Care Unit (CCU) patients. Methods: Twenty-eight CCU patients (1 May 2021–31 January 2022) were monitored using a Libre FreeStyle system. Analyzed data included patient demographic and laboratory data, left ventricular ejection fraction, standard glucose monitoring, APACHE IV scores, and cardiogenic shock occurrence. Analysis was performed using the χ2 test, Mann–Whitney U test, and logistic regression. Results: Among the patients, 13 (46.43%) developed cardiogenic shock. FGM detected hypoglycemia in 18 (64.29%) patients, while standard methods in 6 (21.43%) patients. FGM-detected hypoglycemia was more frequent in patients who developed cardiogenic shock (p = 0.0129, χ2 test) with a significantly higher time below range reading (p = 0.0093, Mann Withney U test), despite no differences in mean glucose values. In addition, hypoglycemia detected by FGM was an independent predictor of shock (p = 0.0390, logistic regression). Conclusions: FGM identified more hypoglycemic events compared to standard glucose monitoring in the CCU. Frequent FGM-detected hypoglycemic events were associated with cardiogenic shock, regardless of a history of diabetes. Due to a limited sample size, these results should be interpreted cautiously and further research in this area is justified.
No takes yet. Share an insight, caveat, or question.
Altabas et al. (2025) conducted an observational in Critically ill Coronary Care Unit (CCU) patients (n=28). Flash glucose monitoring (FGM) vs. Standard glucose monitoring was evaluated on Cardiogenic shock occurrence (p=0.0390). Flash glucose monitoring detected more hypoglycemic events than standard monitoring, and FGM-detected hypoglycemia was an independent predictor of cardiogenic shock.
Synapse has enriched 10 related papers. Consider them for comparative context: